Boston Scientific Inc. (BSX): Today's Featured Health Care Laggard

Boston Scientific ( BSX) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.2%. By the end of trading, Boston Scientific fell $0.18 (-1.9%) to $9.03 on average volume. Throughout the day, 28,388,392 shares of Boston Scientific exchanged hands as compared to its average daily volume of 19,329,300 shares. The stock ranged in price between $9.02-$9.41 after having opened the day at $9.31 as compared to the previous trading day's close of $9.21. Other companies within the Health Care sector that declined today were: Pingtan Marine Enterprise ( PME), down 65.0%, DARA Biosciences ( DARA), down 10.2%, Infinity Pharmaceuticals ( INFI), down 9.9% and China Pharma ( CPHI), down 9.1%.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $12.3 billion and is part of the health services industry. Shares are up 60.7% year to date as of the close of trading on Monday. Currently there are 5 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates Boston Scientific as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow and feeble growth in its earnings per share.

On the positive front, CombiMatrix Corporation ( CBMX), up 42.8%, USMD Holdings ( USMD), up 17.5%, Genvec ( GNVC), up 14.2% and Oncolytics Biotech ( ONCY), up 13.0% , were all gainers within the health care sector with Celgene Corporation ( CELG) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Dow Sinks for Eighth Straight Session; Intel's CEO Departs -- ICYMI

Dow Sinks for Eighth Straight Session; Intel's CEO Departs -- ICYMI

Dow Logs Eighth Straight Drop as Stocks Slump

Dow Logs Eighth Straight Drop as Stocks Slump

This Is What's Hot Thursday - Stocks Slide, Intel's CEO Woes & Major Movers

This Is What's Hot Thursday - Stocks Slide, Intel's CEO Woes & Major Movers

U.S. Banks Pass Fed 'Stress Test' With Room for Dividends, Buybacks

U.S. Banks Pass Fed 'Stress Test' With Room for Dividends, Buybacks

U.S. Drillers at Mercy of Iran, Saudi Production Spat as OPEC Meeting Begins

U.S. Drillers at Mercy of Iran, Saudi Production Spat as OPEC Meeting Begins